ACAD Acadia Pharmaceuticals
$19.74 -1.84%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-1.84%
YTD
-8.40%
P/E
9.05
P/B
3.68
ROE
32.4%
Div yield
—
Beta
0.75
Market cap
$3.4B
RSI (14)
17
Next earnings
Nov 3, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$20.16
Close
$19.74
VWAP (n/a)
—
Day high
$20.36
Day low
$19.67
Volume
1.7M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Acadia Pharmaceuticals (ACAD) Secures Patent And Phase 2 Progress, Is It 38% Below Fair Value?
Yahoo Finance · Oct 6
Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to March 2041
Yahoo Finance · Sep 28
3 Stocks Put Traders Are Targeting Today: AMTX, ACAD, REZI
Yahoo Finance · Sep 28
Acadia Pharmaceuticals (ACAD) Stock Trades At A Discount After A 29% Drop
Yahoo Finance · Sep 27
ACAD Stock Tumbles Today: Analysts Weigh RADIANT Results, Cut Price Targets
Yahoo Finance · Sep 25
Acadia chugs on with Alzheimer’s psychosis programme despite Phase II miss
Yahoo Finance · Sep 25
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 24, 2026 View → 8-K Sep 11, 2026 View → 10-Q Aug 5, 2026 View → 8-K Aug 4, 2026 View → 8-K May 29, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell ACAD. Try it in the Lab to size a position and see the risk.